117 related articles for article (PubMed ID: 9688007)
21. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
22. Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.
Kaibori M; Matsui Y; Kitade H; Kwon AH; Kamiyama Y
Hepatogastroenterology; 2003; 50(50):491-6. PubMed ID: 12749254
[TBL] [Abstract][Full Text] [Related]
23. [Histological study of the effect of pre-transplant chemoembolization of hepatocellular carcinoma].
Zurera LJ; Canis M; Marchal T; García-Revillo J; Martos JM; Benito A; Fraga E
Radiologia; 2008; 50(1):47-53. PubMed ID: 18275789
[TBL] [Abstract][Full Text] [Related]
24. Clinical profile and liver explant findings in patients with and without pretransplant downstaging for hepatocellular carcinoma.
Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2399-402. PubMed ID: 23026605
[TBL] [Abstract][Full Text] [Related]
25. [Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma].
Wang QX; Yan JJ; Zhou FG; Shen J; Yan YQ
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):748-51. PubMed ID: 19615209
[TBL] [Abstract][Full Text] [Related]
26. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
Millonig G; Graziadei IW; Freund MC; Jaschke W; Stadlmann S; Ladurner R; Margreiter R; Vogel W
Liver Transpl; 2007 Feb; 13(2):272-9. PubMed ID: 17256758
[TBL] [Abstract][Full Text] [Related]
27. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
28. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
[TBL] [Abstract][Full Text] [Related]
29. Conventional Chemoembolization Plus Radiofrequency Ablation versus Surgical Resection for Single, Medium-Sized Hepatocellular Carcinoma: Propensity-Score Matching Analysis.
Lee HJ; Kim JW; Hur YH; Cho SB; Lee BC; Lee BK; Hwang EC; Cho YS; Seon HJ
J Vasc Interv Radiol; 2019 Mar; 30(3):284-292.e1. PubMed ID: 30819467
[TBL] [Abstract][Full Text] [Related]
30. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
Lin Z; Ren Z; Xia J
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):315-7. PubMed ID: 11778559
[TBL] [Abstract][Full Text] [Related]
31. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma?
Harada T; Matsuo K; Inoue T; Tamesue S; Inoue T; Nakamura H
Ann Surg; 1996 Jul; 224(1):4-9. PubMed ID: 8678616
[TBL] [Abstract][Full Text] [Related]
32. Effect of preoperative transcatheter arterial chemoembolization on tumor cell activity in hepatocellular carcinoma.
Huang J; He X; Lin X; Zhang C; Li J
Chin Med J (Engl); 2000 May; 113(5):446-8. PubMed ID: 11776102
[TBL] [Abstract][Full Text] [Related]
33. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
Tung-Ping Poon R; Fan ST; Wong J
Ann Surg; 2000 Jul; 232(1):10-24. PubMed ID: 10862190
[TBL] [Abstract][Full Text] [Related]
34. Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
Seo DD; Lee HC; Jang MK; Min HJ; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ; Ko GY; Lee YJ; Lee SG
Ann Surg Oncol; 2007 Dec; 14(12):3501-9. PubMed ID: 17899289
[TBL] [Abstract][Full Text] [Related]
35. Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma.
Fan J; Tang ZY; Yu YQ; Wu ZQ; Ma ZC; Zhou XD; Zhou J; Qiu SJ; Lu JZ
Dig Surg; 1998; 15(6):674-8. PubMed ID: 9845635
[TBL] [Abstract][Full Text] [Related]
36. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study.
Liu Y; Yang R
J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841
[TBL] [Abstract][Full Text] [Related]
37. Effect of Bridging Local-Regional Therapy on Recurrence of Hepatocellular Carcinoma and Survival after Orthotopic Liver Transplantation.
Oligane HC; Xing M; Kim HS
Radiology; 2017 Mar; 282(3):869-879. PubMed ID: 27673508
[TBL] [Abstract][Full Text] [Related]
38. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Int J Oncol; 2013 Jan; 42(1):151-60. PubMed ID: 23174998
[TBL] [Abstract][Full Text] [Related]
39. Combined Therapy of Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Surgical Resection for Single 2-3 cm Hepatocellular Carcinoma: A Propensity-Score Matching Analysis.
Lee HJ; Kim JW; Hur YH; Shin SS; Heo SH; Cho SB; Kang YJ; Lim HS; Seon HJ; Jeong YY
J Vasc Interv Radiol; 2017 Sep; 28(9):1240-1247.e3. PubMed ID: 28688816
[TBL] [Abstract][Full Text] [Related]
40. Preoperative transarterial chemoembolization for hepatocellular carcinoma.
Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
Hepatogastroenterology; 2012 Oct; 59(119):2295-9. PubMed ID: 23435144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]